Get the Stockscreener App
35.98
1.20%
0.48
Blackrock Health Sciences Trust Stock (BME) Forecast
The Blackrock Health Sciences Trust (BME) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $38.61, representing a +7.31% increase from the current price of $35.98. The highest analyst price target is $39.58, and the lowest is $37.64.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BME Price Target
Average 35.65
(-0.90% Downside)
Is Blackrock Health Sciences Trust (BME) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.73 | Neutral |
| STOCH(9,6) | 54.15 | Neutral |
| STOCHRSI(14) | 97.28 | Sell |
| MACD(12,26) | -0.8631 | Buy |
| ADX(14) | 42.80 | Sell |
| William %R | -61.74 | Neutral |
| CCI(14) | -17.68 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
35.80
Buy
|
36.07
Sell
|
| MA20 |
36.88
Sell
|
36.72
Sell
|
| MA50 |
38.58
Sell
|
37.95
Sell
|
| MA100 |
38.91
Sell
|
38.79
Sell
|
| MA200 |
40.07
Sell
|
39.50
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BME could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BME, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.73 indicates that BME is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.15 indicates that BME is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 97.28 indicates that BME is oversold. This suggests that BME price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.8 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -17.68 indicates that BME is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BME price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Blackrock Health Sciences Trust financial reports and earnings history, Blackrock Health Sciences Trust (BME) stock could reach $24.46 by 2030, $4.6656 by 2040 and $25.87 by 2050. See the projected annual prices until 2050 of the Blackrock Health Sciences Trust stock below:
- Blackrock Health Sciences Trust (BME) is expected to reach an average price of $11.48 in 2035, with a high prediction of $12.96 and a low estimate of $10.78. This indicates an $-68.09% rise from the last recorded price of $35.98.
- Blackrock Health Sciences Trust (BME) stock is projected to chart a bullish course in 2040, with an average price target of $3.0139, representing an $-91.62% surge from its current level. The forecast ranges from a conservative $2.8939 to a sky-high $4.6656.
- Our analysts predict Blackrock Health Sciences Trust (BME) to jump -66.67% by 2045, soaring from $12.44 to an average price of $11.99, potentially reaching $12.81. While $12.44 is the low estimate, the potential upside is significant.
- Blackrock Health Sciences Trust (BME) stock is expected to climb by 2050, reaching an average of $26.24, a $-27.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.87 and $25.61, respectively, highlighting the market's uncertainty.
Blackrock Health Sciences Trust Stock (BME) Year by Year Forecast
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2025
Blackrock Health Sciences Trust Stock (BME) is expected to reach an average price of $35.97 in 2025, with a high prediction of $39.66 and a low estimate of $32.28. This indicates an -0.03% fall from the last recorded price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $39.10 | $37.64 | $39.58 | +8.68% |
| June, 2025 | $39.38 | $38.64 | $39.56 | +9.45% |
| July, 2025 | $35.31 | $35.29 | $39.38 | -1.87% |
| August, 2025 | $35.94 | $35.31 | $36.57 | -0.10% |
| September, 2025 | $35.10 | $32.46 | $37.41 | -2.44% |
| October, 2025 | $34.99 | $34.29 | $36.47 | -2.75% |
| November, 2025 | $33.24 | $32.70 | $35.77 | -7.61% |
| December, 2025 | $33.99 | $32.90 | $34.15 | -5.53% |
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2026
The predicted value for Blackrock Health Sciences Trust (BME) in 2026 is set at an average of $32.75. Estimates vary from a peak of $36.46 to a trough of $29.03, indicating an -8.99% surge from the present price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $33.54 | $33.01 | $34.38 | -6.77% |
| February, 2026 | $32.82 | $32.67 | $33.76 | -8.77% |
| March, 2026 | $33.06 | $32.78 | $33.74 | -8.13% |
| April, 2026 | $31.94 | $31.73 | $33.42 | -11.22% |
| May, 2026 | $31.34 | $29.03 | $32.44 | -12.91% |
| June, 2026 | $32.03 | $30.44 | $32.03 | -10.99% |
| July, 2026 | $34.05 | $31.89 | $34.05 | -5.38% |
| August, 2026 | $34.59 | $33.78 | $36.46 | -3.87% |
| September, 2026 | $35.99 | $34.45 | $36.40 | +0.01% |
| October, 2026 | $34.85 | $34.83 | $36.39 | -3.15% |
| November, 2026 | $32.17 | $32.15 | $35.44 | -10.60% |
| December, 2026 | $32.70 | $32.18 | $34.02 | -9.12% |
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Blackrock Health Sciences Trust (BME) is $29.52, with a high forecast of $33.26 and a low forecast of $25.78. This indicates an -17.95% decrease from the last price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $32.04 | $29.07 | $32.11 | -10.96% |
| February, 2027 | $31.63 | $30.93 | $33.11 | -12.08% |
| March, 2027 | $30.31 | $29.36 | $32.41 | -15.75% |
| April, 2027 | $30.67 | $29.76 | $30.83 | -14.76% |
| May, 2027 | $30.23 | $29.69 | $31.07 | -15.97% |
| June, 2027 | $29.85 | $29.38 | $30.46 | -17.03% |
| July, 2027 | $29.24 | $29.24 | $30.45 | -18.73% |
| August, 2027 | $28.69 | $28.48 | $29.91 | -20.27% |
| September, 2027 | $27.37 | $25.78 | $29.19 | -23.92% |
| October, 2027 | $28.94 | $27.30 | $29.09 | -19.56% |
| November, 2027 | $30.84 | $28.67 | $30.84 | -14.29% |
| December, 2027 | $31.92 | $30.58 | $33.26 | -11.29% |
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2028
In 2028, Blackrock Health Sciences Trust (BME) is projected to reach an average price of $28.76, with a high projection of $33.22 and a low estimate of $24.30. This indicates an -20.06% fall from the last price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $32.81 | $31.75 | $33.22 | -8.80% |
| February, 2028 | $31.69 | $31.67 | $33.22 | -11.93% |
| March, 2028 | $29.39 | $29.01 | $32.29 | -18.32% |
| April, 2028 | $29.31 | $28.99 | $30.63 | -18.54% |
| May, 2028 | $28.40 | $25.69 | $29.27 | -21.07% |
| June, 2028 | $27.86 | $27.57 | $29.75 | -22.57% |
| July, 2028 | $26.97 | $26.02 | $28.15 | -25.04% |
| August, 2028 | $26.37 | $26.37 | $27.50 | -26.71% |
| September, 2028 | $26.80 | $26.39 | $27.77 | -25.51% |
| October, 2028 | $26.56 | $26.09 | $27.17 | -26.17% |
| November, 2028 | $26.07 | $25.97 | $27.17 | -27.54% |
| December, 2028 | $24.30 | $24.30 | $26.65 | -32.45% |
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2029
The 2029 price forecast for Blackrock Health Sciences Trust Stock (BME) is $26.18 on average, with a high prediction of $30.06 and a low estimate of $22.30. This represents an -27.24% decrease from the previous price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.57 | $22.53 | $25.12 | -31.71% |
| February, 2029 | $25.67 | $24.50 | $25.87 | -28.64% |
| March, 2029 | $28.87 | $25.74 | $29.48 | -19.77% |
| April, 2029 | $28.73 | $27.92 | $30.06 | -20.16% |
| May, 2029 | $29.35 | $28.57 | $30.06 | -18.44% |
| June, 2029 | $28.24 | $28.12 | $29.95 | -21.52% |
| July, 2029 | $26.25 | $25.86 | $29.14 | -27.04% |
| August, 2029 | $22.41 | $22.30 | $27.24 | -37.72% |
| September, 2029 | $25.03 | $22.41 | $25.90 | -30.44% |
| October, 2029 | $24.07 | $23.82 | $26.40 | -33.09% |
| November, 2029 | $23.57 | $22.67 | $24.39 | -34.49% |
| December, 2029 | $23.05 | $23.05 | $24.18 | -35.94% |
Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2030
Blackrock Health Sciences Trust Stock (BME) is expected to reach an average price of $22.90 in 2030, with a high forecast of $26.89 and a low forecast of $18.91. This signifies an -36.35% decrease from the last price of $35.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.25 | $23.07 | $24.46 | -35.39% |
| February, 2030 | $23.53 | $22.80 | $23.88 | -34.59% |
| March, 2030 | $22.80 | $22.69 | $23.85 | -36.63% |
| April, 2030 | $21.05 | $21.05 | $23.39 | -41.50% |
| May, 2030 | $21.34 | $19.28 | $21.88 | -40.70% |
| June, 2030 | $22.45 | $21.27 | $22.65 | -37.59% |
| July, 2030 | $26.60 | $22.52 | $26.86 | -26.06% |
| August, 2030 | $25.66 | $24.73 | $26.52 | -28.68% |
| September, 2030 | $26.18 | $25.39 | $26.89 | -27.25% |
| October, 2030 | $25.69 | $24.96 | $26.79 | -28.59% |
| November, 2030 | $23.39 | $22.72 | $25.82 | -34.99% |
| December, 2030 | $19.02 | $18.91 | $24.07 | -47.13% |
0.58%
2.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):